Metir plc engages in research, development, and commercialization of miniaturized mass spectrometry instruments in the United Kingdom, the United States, the European Union, China, and Qatar. It offers compact mass spectrometers under the Microsaic 4500 MiD brand; Modern Water MicroTox CTM, FX, and LX toxicity monitors; consumables and spare parts; product support services, such as training sales and service teams; and assurance warranties. The company also provides science and engineering consultancy, laboratory services, and monitoring services; reagents under the Microtox brand; and sulphate reducing bacteria kits under the QuickChek. In addition, it is involved in the large-scale potable water monitoring projects, including the installation of the online live data Continuous Toxicity Monitoring system in Qatar. It sells its products through OEMs and distribution sales channels. The company was formerly known as Microsaic Systems plc and changed its name to Metir plc in February 2025. Metir plc was incorporated in 1998 and is based in York, the United Kingdom.…
Metir Plc (LSE:MET): The Next Catalyst Could Shape the Market Story for This Small-Cap Growth Stock
Metir (LON: MET) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Scientific & Technical Instruments industry, part of the Technology sector, and reports about 5 employees.
The shares were at 0.2750 GBp on 20 November 2026, down 65.6% over 52 weeks. Its 52-week range is 0.2500 GBp to 0.9500 GBp: the price is 71.1% below the high and 10.0% above the low.
Its market capitalisation is 2.62M GBP.
Metir reports return on equity of -70.1%, an operating margin of -124.6% and revenue down 60.1% year over year.
It holds more cash than debt, a net cash position of 308.00K GBP. Its Piotroski F-score is 6 out of 9, an average reading of its financial health.
No upcoming events tracked.